CD33 and acute myeloid leukemia: Five additional single-nucleotide polymorphisms (SNPs) in the CD33 gene (rs1803254, rs35112940, rs2455069, rs61736475, and rs201074739) have been identified in patients with AML, which may modulate the anti-leukemic effect of GO [22,23].